Drug Transport - Pelis 1 Flashcards

1
Q

ADME

A

Drug absorption, distribution, metabolism and excretion

Influenced by drug transporters and metabolizing enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Class 1 Drugs

A

High solubility, high permeability

Metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Class 2 Drugs

A

Low solubility, high permeability

Metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Class 3 Drugs

A

High solubility, low permeability
Renal or bile excretion
Need transporters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Class 4 Drugs

A

Low solubility, low permeability
Renal or bile excretion
Need transporters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ATP binding cassette

A

ABC

Hydrolyze ATP to pump drugs out of cells (efflux pumps)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Solute carrier family

A

SLC
Energy in solute gradient, ie. Na, to move drugs in or out of cells
Uptake or efflux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Epithelial transport

A

Drug transporters facilitate transport of therapeutic drugs and more across epithelia
Transporters considered important for pharmacokinetics and their predominant direction of transport
Biliary, renal secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Substrates of transporters

A

Low MW
Neutral, organic cations/anions, zwitterions
Endogenous compounds
Xenobiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Efflux transporters

A

P-glygoprotein
Multidrug resistance association proteins
Breast cancer resistance protein
Multidrug and toxin extruder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Uptake transporters

A

OCTs, OATs, organic anion transporting polypeptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

P-glycoprotein

A
Pgp
Efflux transporter
Neutral, organic ions
First drug transporter identified
~50% of marketed on drugs are substrates
Absent from CSF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Multidrug resistance association proteins

A

Organic anions

Efflux transporter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Breast cancer resistance protein

A

BCRP
Efflux transporter
Neutral and organic anions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Multidrug and toxin extruder

A

MATE1
Efflux transporter
Organic cations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

OCT

A

Uptake transporter

Organic cations

17
Q

OAT

A

Uptake transporter

Organic anion

18
Q

Organic anion transporting polypeptide

A

OATP
Uptake transporter
Organic anions

19
Q

Transporter effects on oral bioavailability

A

Can either increase or decrease, some transporters can be highjacked to increase oral bioavailability
Efflux pumps like Pgp reduce oral bioavailability

20
Q

Digoxin

A

Cardiac glycoside used for atrial fibrillation and heart failure
Low therapeutic index
Pgp reduces bioavailability
Absorption increases with Pgp inhibition

21
Q

Acylcovir

A

Low bioavailability
Antiviral drug
Valacyclovir (prodrug) is a substrate of PEPT1 and is readily absorbed

22
Q

OATP1B1

A

Reduced P1B1, statins build up and could cause myopathy

23
Q

Cisplatin

A

Easily transported into kidneys and can kill the kidney

24
Q

Probenecid

A

Slows down renal penicillin transport
Allows lower doses of penicillin
Take with cidofovir to prevent nephrotoxicity

25
Q

2 questions of drug development

A
  1. Does out new chemical entity inhibit other transporters and enzymes?
  2. What transporters and enzymes are involved in ADME of our NCE
26
Q

In vitro tools in drug development

A
  1. Nonpolarized cells (human embryonic kidney cells, Chinese hamster ovary cells, Xenopus oocytes)
  2. Polarized cells (Madin Darby Canine Kindey, Porcine kidney cell line)
  3. Inside-out membrane vesicles (efflux transporters)
  4. Caco-2 (intestine or BBB model)
  5. Primary hepatocytes (liver model)
27
Q

Why not use animal models?

A

Differences in transporters

28
Q

Caco2 assay

A

Efflux transporter phenotyping and passive permeability assessment
Routine assay, first done in drug development
Observe net flux ratio and inhibition by Pgp inhibitors

29
Q

Physiological-based pharmacokinetic modeling

A

Used to predict drug exposure and response in virtual human populations using in vitro data